Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis
暂无分享,去创建一个
F. Rosendaal | H. Janssen | B. van Hoek | F. Leebeek | M. Tanck | M. D. de Maat | S. Murad | S. Darwish Murad | E. Haagsma | E. D. de Bruijne | E. L. de Bruijne